Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 27 Jul 2010, 15:23 CSP - Chemical Specialities Limited - Results of special general meeting held on
CSP
CSP                                                                             
CSP - Chemical Specialities Limited - Results of special general meeting held on
27 July 2010 and SRP ruling                                                     
Chemical Specialities Limited                                                   
Incorporated in the Republic of South Africa)                                   
Registration number 2005/039947/06)                                             
Share code: CSP                                                                 
ISIN: ZAE000109427                                                              
("Chemspec" or "the Company")                                                   
RESULTS OF SPECIAL GENERAL MEETING HELD ON 27 JULY 2010 AND SRP RULING          
RESULTS OF GENERAL MEETING                                                      
Chemspec shareholders ("the Chemspec Shareholders") are referred to the Chemspec
Rights Offer circular to Chemspec Shareholders dated 28 June 2010 ("the         
Circular"). All of the resolutions tabled to approve and implement the corporate
actions set forth in the Circular were passed by the requisite majority of      
shareholders. 99.99% of Chemspec shareholders voted in favour of all the        
resolutions proposed at the special general meeting held today ("the General    
Meeting").                                                                      
SRP RULING IN FAVOUR OF THE WAIVER OF THE MANDATORY OFFER                       
At today`s General Meeting, 99.99% of independent Chemspec Shareholders, as     
contemplated in the  Securities Regulation Panel ("SRP") Code and, in terms of  
Rule 8.1 of the SRP Code, have voted in favour of the waiver of a mandatory     
offer resolution as more fully described in the Circular.                       
In terms of, inter alia, Rule 8.7 of the SRP Code the SRP may waive the         
requirement to make a mandatory offer if (inter alia) such waiver is supported  
by a majority of independent shareholders in general meeting.  The SRP has      
advised that it will be willing to consider an application to grant the         
abovementioned waiver, subject to independent Chemspec Shareholders (as         
contemplated in the Circular) passing an ordinary resolution in general meeting 
approving a waiver of their right to require Corvest and/or RMBAM (as defined in
the Circular) to make a mandatory offer at 90 cents per Chemspec share under    
Rule 8.1 of the SRP Code ("the Mandatory Offer").                               
Prior to granting this waiver, the SRP will consider any objections or          
representations made by parties as contemplated below:                          
1.Any interested party who wishes to object to the dispensation shall have at   
least 14 (fourteen) calendar days from the date of this announcement to raise   
such an objection with the SRP. Objections should be made in writing and        
addressed to the "Executive Director, Securities Regulation Panel" at any one   
of the following addresses:                                                     
 Physical           Postal             Fax                                      
Ground Floor       PO Box 91833       +27 11 482 5635                          
2 Sherborne Road   Auckland Park                                                
 (off Jan Smuts     2006                                                        
 Avenue)                                                                        
Parktown                                                                       
Johannesburg                                                                    
 2193                                                                           
2.Objections should reach the SRP by no later than close of business on Tuesday,
10 August 2010 in order to be considered.                                       
3.If any submissions are made to the SRP within the permitted timeframe, the SRP
will consider the merits thereof and, if necessary, provide the objectors with  
an opportunity to make representations to the SRP.         4.Thereafter, subject
to the waiver having been approved by Chemspec Shareholders in general meeting  
(which was obtained in today`s General Meeting ), the SRP will rule on the      
requirement for a Mandatory Offer.                                              
Canelands                                                                       
27 July 2010                                                                    
Designated Advisor: QuestCo Sponsors (Pty) Ltd                                  
Fund Raising Advisor: Purple Capital Ltd                                        
Attorneys to the rights offer: Edward Nathan Sonnenbergs                        
Date: 27/07/2010 15:23:20 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.                                          
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: